Alumnus David Fischell, ’75, MS ’78, PhD 80′, Chairman and CEO Angel Medical Systems, will be speaking at the Enterprise Engineering Colloquium on October 16 @ 4:30 pm, B-11 Kimball Hall.

Medical devices provide an important avenue of therapeutics and diagnostics improving human healthcare. Dr. Fischell is an inventor and serial entrepreneur who has helped found 15 medical device companies over the last 25 years. He will discuss the field of medical devices and the process by which one takes an idea and gets it into a final product and company.

He will also present results from one or more of his recent start-ups that include:

• Angel Medical Systems (Chairman) – angel-med.com – implantable alarm system for heart
attacks
• Neuropace (Director) – neuropace.com – implantable brain pacemakers to treat epilepsy
• eNeura (Chairman) – eneura.com – portable magnetic pulse generators to cure migraine
headaches and
• Ablative Solutions (Director) – ablativesolutions.com – a novel catheter whose use can cure
or dramatically reduce high blood pressure.

After earning his Cornell Ph.D. in Applied Physics and Electrical Engineering, David joined Bell Laboratories in 1979 where, for 11 years, he performed and directed a wide range of research and development projects including leading an internal venture and the design and development of an integrated platform in the AT&T network for AT&T’s first ever enhanced voice service, InfoworxTM.  He left Bell Labs in 1991 to work full time on medical devices.  He currently has 178 issued U.S. patents and has published numerous papers in the fields of telecommunications, cardiology and radiation dosimetry.  He was the primary designer of the BX Velocity™ and Cypher™ Stents for Cordis, a Johnson & Johnson Company, that were implanted in more than 7 million patients.  Cypher was the world’s first drug eluting stent.

Hosted by Operations Research & Information Engineering (ORIE)

CONTACT: John Callister jc62@cornell.edu 607-339-7420